Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic, Autoimmune

Explore clinical trials studying Anemia, Hemolytic, Autoimmune. Study availability and eligibility vary by location and protocol.

67 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic, Autoimmune trial results

Completed

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)

NCT05096403

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • University of Iowa Hospitals & Clinics - The Hemophilia Treatment Center (HTC) Iowa City, Iowa, United States
  • Weill Cornell Medicine / NewYork Presbyterian Hospital New York, United States
View all 44 locations
View Trial Details
Completed

A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease

NCT04269551

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • Investigational Site Number :8400002 Fayetteville, Georgia, United States
  • Investigational Site Number :8400009 St Louis, Missouri, United States
  • Investigational Site Number :8400006 The Bronx, New York, United States
  • Investigational Site Number :8400008 Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan

NCT05132127

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • Investigational Site Number 3920005 Ishikawa, Japan
  • Investigational Site Number 3920004 Kanagawa, Japan
  • Investigational Site Number 3920003 Osaka, Japan
  • Investigational Site Number 3920002 Saitama, Japan
View Trial Details
Completed

A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

NCT03538041

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +16 more
Locations
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

NCT03226678

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +6 more
Locations
  • American Institute of Research Whittier, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • Mid Florida Hematology Oncology Orange City, Florida, United States
  • University of Iowa Hospitals Iowa City, Iowa, United States
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

NCT03347422

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • Arizona Oncology Associates PC Tucson, Arizona, United States
  • USC/Keck School of Medicine Los Angeles, California, United States
  • Georgetown University Medical Center Georgetown, District of Columbia, United States
  • Cleveland Clinic Florida Weston, Florida, United States
View all 53 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)

NCT03347396

Conditions
Agglutinin Disease, Cold, Anemia, Anemia, Hemolytic, +5 more
Locations
  • Arizona Oncology Associates PC Tucson, Arizona, United States
  • USC/Keck School of Medicine Los Angeles, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Georgetown University Medical Center Georgetown, District of Columbia, United States
View all 49 locations
View Trial Details

Related conditions